CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 79% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English

Trade AstraZeneca PLC - SEK - AZNs CFD

1328.0
0.3%
Market Trading Hours* (UTC) Opens on Monday at 08:00

Mon - Fri: 08:00 - 16:25

  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading Conditions
Spread 4.5
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.021947 %
Charges from full value of position ($-4.17)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.021947%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.000275 %
Charges from full value of position ($-0.05)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.000275%
Overnight fee time 22:00 (UTC)
Min traded quantity 1
Currency SEK
Margin 5%
Stock exchange Sweden
Commission on trade 0%

*Information provided by Capital.com

AstraZeneca PLC ESG Risk Ratings

High Medium Low Negligible

‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.

More ESG coverage

Key Stats
Prev. Close* 1324
Open* 1328.5
1-Year Change* -6.73%
Day's Range* 1325 - 1335.5
52 wk Range 100.12-123.92
Average Volume (10 days) 1.31M
Average Volume (3 months) 34.89M
Market Cap 156.89B
P/E Ratio 33.46
Shares Outstanding 1.55B
Revenue 36.02B
EPS 3.03
Dividend (Yield %) 2.326
Beta 0.29
Next Earnings Date Feb 8, 2024

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Dec 8, 2023 1328.0 8.0 0.61% 1320.0 1337.0 1318.0
Dec 7, 2023 1324.0 0.0 0.00% 1324.0 1341.5 1316.0
Dec 6, 2023 1339.0 -9.0 -0.67% 1348.0 1356.5 1338.0
Dec 5, 2023 1346.0 -8.5 -0.63% 1354.5 1357.0 1335.0
Dec 4, 2023 1356.0 14.0 1.04% 1342.0 1358.0 1337.0
Dec 1, 2023 1348.5 3.5 0.26% 1345.0 1365.4 1341.5
Nov 30, 2023 1341.5 21.0 1.59% 1320.5 1346.0 1316.0
Nov 29, 2023 1324.0 19.5 1.49% 1304.5 1334.0 1303.0
Nov 28, 2023 1308.0 -15.0 -1.13% 1323.0 1324.0 1307.0
Nov 27, 2023 1328.0 -10.5 -0.78% 1338.5 1350.5 1325.5
Nov 24, 2023 1348.5 3.0 0.22% 1345.5 1353.5 1342.5
Nov 23, 2023 1348.0 31.5 2.39% 1316.5 1348.5 1316.5
Nov 22, 2023 1331.5 -11.5 -0.86% 1343.0 1346.5 1330.0
Nov 21, 2023 1334.5 11.5 0.87% 1323.0 1336.5 1323.0
Nov 20, 2023 1328.0 -12.0 -0.90% 1340.0 1340.0 1318.5
Nov 17, 2023 1350.0 -5.0 -0.37% 1355.0 1364.4 1345.0
Nov 16, 2023 1346.5 19.0 1.43% 1327.5 1347.0 1326.0
Nov 15, 2023 1332.5 -31.9 -2.34% 1364.4 1368.9 1330.5
Nov 14, 2023 1365.9 -12.5 -0.91% 1378.4 1383.4 1362.9
Nov 13, 2023 1371.4 3.5 0.26% 1367.9 1387.9 1361.0

AstraZeneca PLC - SEK Events

Time (UTC) Country Event
No events scheduled
View all events
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total revenue 44351 37417 26617 24384 22090
Revenue 44351 37417 26617 24384 22090
Cost of Revenue, Total 8649 9542 5270 4824 4246
Gross Profit 35702 27875 21347 19560 17844
Total Operating Expense 40594 36361 21455 21460 18703
Selling/General/Admin. Expenses, Total 13512 11519 9338 8964 8479
Research & Development 9612 8519 6094 5320 5266
Depreciation / Amortization 4094 3044 1897 1812 1945
Unusual Expense (Income) 5071 3846 -763 863 -953
Other Operating Expenses, Total -344 -109 -381 -323 -280
Operating Income 3757 1056 5162 2924 3387
Interest Income (Expense), Net Non-Operating -815 -819 -716 -766 -775
Other, Net -441 -502 -530 -610 -619
Net Income Before Taxes 2501 -265 3916 1548 1993
Net Income After Taxes 3293 115 3144 1227 2050
Minority Interest -5 -3 52 108 105
Net Income Before Extra. Items 3288 112 3196 1335 2155
Net Income 3288 112 3196 1335 2155
Income Available to Common Excl. Extra. Items 3288 112 3196 1335 2155
Income Available to Common Incl. Extra. Items 3288 112 3196 1335 2155
Dilution Adjustment 0 0
Diluted Net Income 3288 112 3196 1335 2155
Diluted Weighted Average Shares 1560 1427 1313 1301 1267
Diluted EPS Excluding Extraordinary Items 2.10769 0.07849 2.43412 1.02613 1.70087
Dividends per Share - Common Stock Primary Issue 2.89361 2.84245 2.83031 2.89446 2.74532
Diluted Normalized EPS 4.04679 2.22705 1.88804 1.48501 0.85399
Interest Expense (Income) - Net Operating 0 0
Total Extraordinary Items
Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
Total revenue 11416 10879 11207 10982 10771
Revenue 11416 10879 11207 10982 10771
Cost of Revenue, Total 1925 1782 2417 2118 1904
Gross Profit 9491 9097 8790 8864 8867
Total Operating Expense 8960 8330 10113 9737 10232
Selling/General/Admin. Expenses, Total 3592 3196 3469 3353 3340
Research & Development 2570 2299 2525 2357 2431
Depreciation / Amortization 952 954 1034 979 983
Unusual Expense (Income) -285 379 641 1002 1298
Other Operating Expenses, Total 206 -280 27 -72 276
Operating Income 2456 2549 1094 1245 539
Interest Income (Expense), Net Non-Operating -368 -287 -316 -323 -292
Net Income Before Taxes 2088 2262 778 922 247
Net Income After Taxes 1820 1804 902 1642 360
Minority Interest -2 -1 -1 -2 0
Net Income Before Extra. Items 1818 1803 901 1640 360
Net Income 1818 1803 901 1640 360
Income Available to Common Excl. Extra. Items 1818 1803 901 1640 360
Income Available to Common Incl. Extra. Items 1818 1803 901 1640 360
Dilution Adjustment
Diluted Net Income 1818 1803 901 1640 360
Diluted Weighted Average Shares 1560 1560 1560 1559 1560
Diluted EPS Excluding Extraordinary Items 1.16538 1.15577 0.57756 1.05196 0.23077
Dividends per Share - Common Stock Primary Issue 0.91215 0 1.9694 0 0.93017
Diluted Normalized EPS 1.00614 1.34953 0.90705 0.99743 0.80833
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total Current Assets 22593 26244 19544 15563 15591
Cash and Short Term Investments 6405 6398 7992 6218 5680
Cash 1411 1461 1182 755 893
Cash & Equivalents 4755 4868 6650 4614 3938
Short Term Investments 239 69 160 849 849
Total Receivables, Net 9923 8795 5651 5181 4345
Accounts Receivable - Trade, Net 7508 6324 3956 3813 2995
Total Inventory 4699 8983 4024 3193 2890
Prepaid Expenses 1329 1512 1735 865 1436
Other Current Assets, Total 237 556 142 106 1240
Total Assets 96483 105363 66729 61377 60651
Property/Plant/Equipment, Total - Net 9449 10171 8917 8335 7421
Property/Plant/Equipment, Total - Gross 17192 18495 17110 15852 14639
Accumulated Depreciation, Total -7743 -8324 -8193 -7517 -7218
Goodwill, Net 19820 19997 11845 11668 11707
Intangibles, Net 39307 42387 20947 20833 21959
Long Term Investments 1142 1237 1147 1459 922
Note Receivable - Long Term 592 504 325 348 515
Other Long Term Assets, Total 3580 4823 4004 3171 2536
Total Current Liabilities 26293 22594 20307 18117 16292
Accounts Payable 2550 2824 2350 1774 1720
Accrued Expenses 8303 8079 4994 5085 5148
Notes Payable/Short Term Debt 261 294 370 154 160
Current Port. of LT Debt/Capital Leases 5281 1599 2016 1856 1594
Other Current Liabilities, Total 9898 9798 10577 9248 7670
Total Liabilities 59446 66095 51107 48250 48183
Total Long Term Debt 23690 28888 17994 16217 17359
Long Term Debt 22965 28134 17505 15730 17359
Capital Lease Obligations 725 754 489 487 0
Deferred Income Tax 2944 6206 2918 2490 3286
Minority Interest 21 19 16 1469 1576
Other Liabilities, Total 6498 8388 9872 9957 9670
Total Equity 37037 39268 15622 13127 12468
Common Stock 387 387 328 328 317
Additional Paid-In Capital 35155 35126 7971 7941 4427
Retained Earnings (Accumulated Deficit) 1495 3755 7323 4858 7724
Total Liabilities & Shareholders’ Equity 96483 105363 66729 61377 60651
Total Common Shares Outstanding 1549.8 1549.4 1312.67 1312.14 1267.04
Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
Total Current Assets 22501 22839 22266 22593 20224
Cash and Short Term Investments 5115 5812 6462 6405 4898
Cash & Equivalents 4871 5664 6232 6166 4458
Short Term Investments 244 148 230 239 440
Total Receivables, Net 11997 11932 10797 11252 10061
Accounts Receivable - Trade, Net 11300 11092 10289 10521 9336
Total Inventory 5292 5051 4967 4699 5078
Other Current Assets, Total 97 44 40 237 187
Total Assets 96086 96543 96687 96483 94185
Property/Plant/Equipment, Total - Net 9700 9624 9599 9449 9227
Goodwill, Net 19939 19960 20001 19820 19707
Intangibles, Net 37687 38326 39291 39307 39585
Long Term Investments 1290 1143 1234 1142 1102
Note Receivable - Long Term 761 752 682 835 792
Other Long Term Assets, Total 4208 3899 3614 3337 3548
Total Current Liabilities 28588 26375 24860 26293 24850
Payable/Accrued 20542 19738 19210 19040 17694
Notes Payable/Short Term Debt 331 271 568 261 584
Current Port. of LT Debt/Capital Leases 5276 4516 3289 5281 5034
Other Current Liabilities, Total 2439 1850 1793 1711 1538
Total Liabilities 58889 59151 60898 59446 59051
Total Long Term Debt 22969 25051 27646 23690 23681
Long Term Debt 22225 24329 26916 22965 23013
Capital Lease Obligations 744 722 730 725 668
Deferred Income Tax 2752 2800 2795 2944 3479
Minority Interest 24 24 22 21 20
Other Liabilities, Total 4556 4901 5575 6498 7021
Total Equity 37197 37392 35789 37037 35134
Common Stock 387 387 387 387 387
Additional Paid-In Capital 35166 35163 35159 35155 35137
Retained Earnings (Accumulated Deficit) 1644 1842 243 1495 -390
Total Liabilities & Shareholders’ Equity 96086 96543 96687 96483 94185
Total Common Shares Outstanding 1549.91 1549.88 1549.85 1549.8 1549.51
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Net income/Starting Line 2501 -265 3916 1548 1993
Cash From Operating Activities 9808 5963 4799 2969 2618
Cash From Operating Activities 5480 6530 3149 3762 3753
Non-Cash Items 542 141 -332 -103 -1276
Cash Taxes Paid 1623 1743 1562 1118 537
Cash Interest Paid 849 721 733 774 676
Changes in Working Capital 1285 -443 -1934 -2238 -1852
Cash From Investing Activities -2960 -11058 -285 -657 963
Capital Expenditures -2571 -2200 -2606 -2460 -1371
Other Investing Cash Flow Items, Total -389 -8858 2321 1803 2334
Cash From Financing Activities -6823 3649 -2203 -1765 -2044
Financing Cash Flow Items -1047 -178 -101 4 -67
Total Cash Dividends Paid -4364 -3856 -3572 -3592 -3484
Issuance (Retirement) of Stock, Net 29 29 30 3525 34
Issuance (Retirement) of Debt, Net -1441 7654 1440 -1702 1473
Foreign Exchange Effects -80 -62 12 5 -38
Net Change in Cash -55 -1508 2323 552 1499
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Net income/Starting Line 2262 2501 1723 800 553
Cash From Operating Activities 3133 9808 7410 4480 3232
Cash From Operating Activities 1502 5480 4000 2666 1309
Non-Cash Items -391 542 172 15 -12
Cash Taxes Paid 225 1623 1335 1006 228
Cash Interest Paid 257 849 608 386 194
Changes in Working Capital -240 1285 1515 999 1382
Cash From Investing Activities -1246 -2960 -2711 -968 -168
Capital Expenditures -1470 -2571 -2017 -906 -363
Other Investing Cash Flow Items, Total 224 -389 -694 -62 195
Cash From Financing Activities -2031 -6823 -6465 -5035 -3740
Financing Cash Flow Items -840 -1047 -1047 -997 -997
Total Cash Dividends Paid -3047 -4364 -4364 -2971 -2971
Issuance (Retirement) of Stock, Net 4 29 11 8 5
Issuance (Retirement) of Debt, Net 1852 -1441 -1065 -1075 223
Foreign Exchange Effects -11 -80 -86 -35 -9
Net Change in Cash -155 -55 -1852 -1558 -685
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
BlackRock Institutional Trust Company, N.A. Investment Advisor 6.5096 100893184 1200 2023-01-31 LOW
Wellington Management Company, LLP Investment Advisor/Hedge Fund 4.1998 65092368 768 2023-01-31 LOW
Investor AB Private Equity 3.3298 51608948 608 2023-01-31 LOW
Capital Research Global Investors Investment Advisor 3.1211 48374655 -165706 2023-06-15 LOW
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 2.8719 44511608 671315 2023-06-15 LOW
Norges Bank Investment Management (NBIM) Sovereign Wealth Fund 2.2154 34336042 875 2023-10-01 LOW
Capital World Investors Investment Advisor 1.8709 28997204 474010 2023-06-15 LOW
BlackRock Investment Management (UK) Ltd. Investment Advisor/Hedge Fund 1.3307 20624979 125455 2023-10-01 LOW
BlackRock Advisors (UK) Limited Investment Advisor/Hedge Fund 1.1707 18144143 -35319 2023-10-01 LOW
GQG Partners, LLC Investment Advisor 1.0711 16600615 66511 2023-06-15 MED
Legal & General Investment Management Ltd. Investment Advisor/Hedge Fund 0.9319 14443159 -63166 2023-10-01 LOW
State Street Global Advisors (UK) Ltd. Investment Advisor/Hedge Fund 0.7607 11789511 0 2023-10-01 LOW
Fidelity Management & Research Company LLC Investment Advisor 0.6104 9460420 45825 2023-10-01 LOW
Nuveen LLC Pension Fund 0.5685 8811257 378713 2023-06-15 LOW
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.5618 8707369 257289 2023-06-15 LOW
Aviva Investors Global Services Limited Investment Advisor/Hedge Fund 0.5266 8162319 -429899 2023-10-01 LOW
Handelsbanken Kapitalförvaltning AB Investment Advisor/Hedge Fund 0.5212 8078066 1670 2023-09-30 LOW
M&G Investment Management Ltd. Investment Advisor 0.4752 7364510 948 2023-10-01 LOW
State Street Global Advisors (US) Investment Advisor/Hedge Fund 0.4611 7146065 10590 2023-10-01 LOW
Union Investment Privatfonds GmbH Investment Advisor 0.4173 6467102 30000 2023-06-30 LOW

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

AstraZeneca - SEK Company profile

AstraZeneca is a multinational biopharmaceutical company that resulted from the merger between the Swedish Astra AB and the English Zeneca Group in 1999. The company is engaged in developing and manufacturing products to treat oncology, cardiovascular & metabolic disease (CVMD) and pursues therapies in autoimmunity, infection and neuroscience. Its R&D headquarters are located in Warsaw, Poland, while its corporate base is in London, England. AstraZeneca is listed on the stock exchanges in London, New York and Stockholm under the ticker AZN. The AZN stock belongs to the FTSE 100 Index. Follow the latest developments of the AstraZeneca share price at Capital.com.
Industry: Pharmaceuticals (NEC)

1 Francis Crick Avenue
CAMBRIDGE
CAMBRIDGESHIRE CB2 0AA
GB

Income Statement

  • Annual
  • Quarterly

News

December RBA preview: no move expected at the final meeting of 2023

The RBA meets on Tuesday, 5th of December, 2023, at 2.30 PM (AEDT). We preview what to expect from this month’s decision.

14:47, 4 December 2023

CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

12:39, 30 November 2023

Euro Zone CPI expected to continue dropping; economists warn about cutting too soon

EZ PI expected to drop further but speed of decline

08:16, 29 November 2023

A weaker Dollar drives gold higher

Gold prices have returned above $US2000 per ounce. We run through the factors driving gold and the commodity’s key technicals.

13:49, 28 November 2023

Q3 US Earnings Recap: Profits surprise to the upside, but outlook remains uncertain

US earnings for the third quarter were far better than expected. However, uncertainty about the outlook for company profits continues. We review the quarterly earnings and look ahead to what the markets expect from S&P 500 companies going forward.

13:20, 28 November 2023

RBNZ Preview: Rates expected to remain unchanged at final meeting of 2023

The RBNZ meets for the final time this year on Wednesday, 29th of November, 2023. We preview what to expect and how it could impact the New Zealand Dollar.

13:04, 28 November 2023

Crude prices slide on OPEC+ uncertainty

Crude prices have chopped sideways amid signs of turmoil within OPEC+. We look at the fundamentals of the oil market and the technical levels of WTI.

12:55, 28 November 2023

People also watch

Oil - Crude

71.81 Price
+0.540% 1D Chg, %
Long position overnight fee -0.0204%
Short position overnight fee -0.0015%
Overnight fee time 22:00 (UTC)
Spread 0.040

US100

16,044.20 Price
-0.200% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0040%
Overnight fee time 22:00 (UTC)
Spread 1.8

XRP/USD

0.63 Price
-6.620% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 22:00 (UTC)
Spread 0.01168

BTC/USD

42,374.25 Price
-3.730% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 106.00

Still looking for a broker you can trust?

Join the 570.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading